Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.18 - $0.84 $774 - $3,612
4,300 Added 7.98%
58,200 $19,000
Q3 2023

Nov 14, 2023

BUY
$0.24 - $0.53 $2,040 - $4,505
8,500 Added 18.72%
53,900 $13,000
Q2 2023

Aug 11, 2023

BUY
$0.44 - $0.73 $6,248 - $10,366
14,200 Added 45.51%
45,400 $23,000
Q1 2023

May 12, 2023

BUY
$0.41 - $1.3 $7,011 - $22,230
17,100 Added 121.28%
31,200 $16,000
Q4 2022

Feb 13, 2023

BUY
$1.1 - $50.0 $2,640 - $120,000
2,400 Added 20.51%
14,100 $16,000
Q3 2022

Nov 14, 2022

BUY
$2.0 - $46.8 $200 - $4,680
100 Added 0.86%
11,700 $26,000
Q2 2022

Aug 12, 2022

BUY
$1.68 - $3.55 $19,488 - $41,180
11,600 New
11,600 $33,000

About Processa Pharmaceuticals, Inc.


  • Ticker PCSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,856,200
  • Market Cap $18.4M
  • Description
  • Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...
More about PCSA
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.